
Here’s what we discussed:
Artificial Intelligence (AI) is rapidly transforming the life sciences and pharmaceutical industries, offering exciting innovations and improvements. Here’s what you can look forward to with AI in Life sciences:
- Faster Drug Discovery: AI accelerates the identification and development of new drugs by analysing vast datasets from generic research, clinical trials, and medical records.
- Improved Clinical Trials: AI enhances the efficiency and effectiveness of clinical trials by identifying the right candidate faster, providing real-time data analysis to ensure safety and compliance, and anticipating outcomes and potential issues.
- Personalized Medicine: AI enables the creation of personalised treatment plans by analysing individual genetic information and medical histories.
- Optimised Supply Chain and Manufacturing: AI optimises every aspect of the supply chain, from production scheduling to inventory management, ensuring the timely delivery of high-quality products while reducing costs and waste.
- Enhanced Data Integration: AI facilitates the integration of data across different systems and platforms, creating comprehensive patient profiles and enabling seamless information exchange.
- Regulatory Compliance: AI automates compliance reporting, ensuring adherence to regulations and reducing the administrative burden on life sciences companies.
The Future is Here with Infosys Life Sciences
The integration of AI in the life sciences and pharmaceutical industries promises a future where innovation is faster, treatments are more effective, and patient care is personalized. Infosys Life Sciences is leading the change in harnessing the potential of AI to revolutionize pharmaceuticals and improve lives.
Infosys hosted a networking dinner with leaders and peers from the Life Sciences industry on “AI in Life Sciences” on January 29, 2025, in New Jersey. Participants explored how AI-driven transformation can harness the power of data for operational efficiency in pharma.
AGENDA
5:00 PM – 5:30 PM
Registration and Networking
5:30 PM – 6:30 PM
MetLife Stadium tour experience
6:30 PM – 7:00 PM
Keynote
From Molecules to Miracles: How AI and GenAI are Redefining Life Sciences
7:00 PM – 7:20 PM
Panel Discussion
Insights on AI Adoption in Commercial Life Sciences; US Pharma Account Case Study: Accelerating the MLR Process with BASE AI Assistant in PromoMats
Hosted & moderated by:
Panelists:

VP, Medical Clinical and
Regulatory Affairs,
Chief Medical Officer
Kaleidoscope Innovation
and Product Design
7:20 PM – 7:40 PM
Panel Discussion
Generative AI across Pharma R&D: A shift towards a productive and collaborative future!
Hosted & moderated by:
Panelists:
7:40 PM – 8:20 PM
Dinner
8:20 PM – 8:30 PM
Closing remarks
This is an executive peer group meeting for 10-12 senior leaders. We use a conversational, story-telling approach that works best when everyone participates.
Dinner at MetLife Stadium, New Jersey


